Main Line biotech firm completes reverse merger, raises $78.9 million
Palvella Therapeutics completed a reverse merger with Pieris Pharmaceutical of Boston to become a public traded company, with ...
Yahoo Finance5d
NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline
“This reverse merger represents a US$452 million transaction at a deemed price of US$3.20 per share —a significant milestone that we believe will enhance market visibility while supporting our ...